{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T19:37:01Z","timestamp":1789414621566,"version":"build-2803163510"},"reference-count":93,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,4,22]],"date-time":"2026-04-22T00:00:00Z","timestamp":1776816000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T00:00:00Z","timestamp":1783036800000},"content-version":"vor","delay-in-days":72,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100005872","name":"Bahir Dar University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005872","id-type":"DOI","asserted-by":"publisher"}]},{"name":"EpiGen-Ethiopia"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Microbiol"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>\n                      <jats:italic>Escherichia coli<\/jats:italic>\n                      (\n                      <jats:italic>E. coli<\/jats:italic>\n                      ) is a Gram-negative, ubiquitous bacterium found in humans, animals, and the environment. Certain strains, notably extended-spectrum \u03b2-lactamase-producing\n                      <jats:italic>E. coli<\/jats:italic>\n                      (ESBL-PEC) and carbapenemase-producing\n                      <jats:italic>E. coli<\/jats:italic>\n                      (CPEC), cause life-threatening intestinal and extraintestinal infections. While some studies exist in patients, data on the prevalence of ESBL-PEC and CPEC among human patients, cattle, and the environment, using a One Health approach, are limited. We aimed to determine the prevalence of ESBL-PEC and CPEC among patients, cattle, and the environment in northwest Amhara, Ethiopia, using a One Health approach.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      A cross-sectional study was conducted from January to August 2025 among 972 study participants, including human patients (508), animals (158), and environmental samples (306). Consecutive sampling was used to select patients and animals. Purposive sampling was used to select environmental samples. Urine or blood from patients, recto-anal mucosal swab from animals, swab, and wastewater from the environment were collected and processed for\n                      <jats:italic>E. coli<\/jats:italic>\n                      isolation using standard microbiological methods. ESBL-PEC and CPEC were identified using a combination disk diffusion test and a modified carbapenem inactivation method, respectively, in accordance with the Clinical Laboratory Standard Institute guidelines. Associations were assessed using Chi-square in SPSS, and antimicrobial resistance (AMR) profiles of\n                      <jats:italic>E. coli<\/jats:italic>\n                      isolates using a heatmap in R software.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      The prevalence of ESBL-PEC among\n                      <jats:italic>E. coli<\/jats:italic>\n                      isolated from patients was 52.4% (33\/63, 95% CI: 40.3\u201364.2), while 33.3% (24\/72, 95% CI: 23.5\u201344.8) among environmental isolates and 6.6% (10\/151, 95% CI: 3.6\u201311.8) among cattle isolates. The prevalence of CPEC among patient isolates was 9.5% (6\/63, 95% CI: 4.4\u201319.3) and 2.8% (2\/72, 95% CI: 0.8\u20139.6) in environmental isolates, while no CPEC was detected among cattle isolates. All ESBL-PEC and CPEC isolates were multidrug resistant (MDR). Among non-\u03b2-lactam antibiotics tested, ESBL-PEC and\/or CPEC isolates showed the highest co-resistance to ciprofloxacin (81.3%), followed by gentamicin (56%), while the lowest was for amikacin (17.3%). Overall, 90.5% (57\/63) of\n                      <jats:italic>E. coli<\/jats:italic>\n                      from patients, and 81.9% (59\/72) from environmental sources, and 29.1% (44\/151) from cattle were MDR.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>\n                      The prevalence of ESBL-PEC and CPEC was high in patients and the hospital environment, whereas ESBL-PEC was low in cattle. No CPEC was detected in cattle. Widespread MDR\n                      <jats:italic>E. coli<\/jats:italic>\n                      presence in patients, the environment, and cattle underscores the need for reinforced infection prevention and control measures in hospitals and AMR surveillance based on a One Health approach.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12866-026-05070-z","type":"journal-article","created":{"date-parts":[[2026,4,22]],"date-time":"2026-04-22T06:15:51Z","timestamp":1776838551000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Prevalence of extended-spectrum \u03b2-lactamase and carbapenemase-producing Escherichia coli from patients, cattle, and environmental sources in northwest Amhara, Ethiopia: a one health approach"],"prefix":"10.1186","volume":"26","author":[{"given":"Chalachew","family":"Genet","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wendemagegn","family":"Enbiale","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Rommerskirchen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rajiha","family":"Abubeker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Atsbeha Gebreegziabxier","family":"Weldemariam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Geremew","family":"Tasew","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tazeb","family":"Molla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Addisu","family":"Melese","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bayeh","family":"Abera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Endalkachew","family":"Nibret","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abaineh","family":"Munshea","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,22]]},"reference":[{"issue":"4","key":"5070_CR1","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1093\/femsre\/fuw005","volume":"40","author":"J Vila","year":"2016","unstructured":"Vila J, S\u00e1ez-L\u00f3pez E, Johnson JR, R\u00f6mling U, Dobrindt U, Cant\u00f3n R, Giske CG, Naas T, Carattoli A, Mart\u00ednez-Medina M, Bosch J, Retamar P, Rodr\u00edguez-Ba\u00f1o J, Baquero F, Soto SM, et al. Escherichia coli: an old friend with new tidings. FEMS Microbiol Rev. 2016;40(4):437\u201363.","journal-title":"FEMS Microbiol Rev"},{"issue":"6","key":"5070_CR2","doi-asserted-by":"publisher","first-page":"fuac031","DOI":"10.1093\/femsre\/fuac031","volume":"46","author":"J Geurtsen","year":"2022","unstructured":"Geurtsen J, de Been M, Weerdenburg E, Zomer A, McNally A, Poolman J. Genomics and pathotypes of the many faces of Escherichia coli. FEMS Microbiol Rev. 2022;46(6):fuac031.","journal-title":"FEMS Microbiol Rev"},{"key":"5070_CR3","doi-asserted-by":"publisher","first-page":"928346","DOI":"10.3389\/fmicb.2022.928346","volume":"13","author":"DB Goulart","year":"2022","unstructured":"Goulart DB, Mellata M. Escherichia coli Mastitis in Dairy Cattle: Etiology, Diagnosis, and Treatment Challenges. Front Microbiol. 2022;13:928346.","journal-title":"Front Microbiol"},{"issue":"2","key":"5070_CR4","doi-asserted-by":"publisher","first-page":"344","DOI":"10.3390\/microorganisms11020344","volume":"11","author":"P Pokharel","year":"2023","unstructured":"Pokharel P, Dhakal S, Dozois CM. The Diversity of Escherichia coli Pathotypes and Vaccination Strategies against This Versatile Bacterial Pathogen. Microorganisms. 2023;11(2):344.","journal-title":"Microorganisms"},{"key":"5070_CR5","doi-asserted-by":"crossref","unstructured":"Manges AR, Johnson JR. Reservoirs of Extraintestinal Pathogenic Escherichia coli. Microbiol Spectr. 2015;3(5).","DOI":"10.1128\/microbiolspec.UTI-0006-2012"},{"key":"5070_CR6","doi-asserted-by":"publisher","unstructured":"Aziz M, Park DE, Quinlivan V, Dimopoulos EA, Wang Y, Sung EH et al. Zoonotic Escherichia coli and urinary tract infections in Southern California. mBio. 2025: e0142825. https:\/\/doi.org\/10.1128\/mBio.01428-25","DOI":"10.1128\/mBio.01428-25"},{"issue":"3","key":"5070_CR7","doi-asserted-by":"publisher","first-page":"e321","DOI":"10.1016\/S2214-109X(18)30483-2","volume":"7","author":"JD Anderson 4th","year":"2019","unstructured":"Anderson JD 4th, Bagamian KH, Muhib F, Amaya MP, Laytner LA, Wierzba T, et al. Burden of enterotoxigenic Escherichia coli and Shigella non-fatal diarrhoeal infections in 79 low-income and lower middle-income countries: a modelling analysis. Lancet Glob Health. 2019;7(3):e321\u201330.","journal-title":"Lancet Glob Health"},{"issue":"10459","key":"5070_CR8","doi-asserted-by":"publisher","first-page":"1199","DOI":"10.1016\/S0140-6736(24)01867-1","volume":"404","author":"GBD 2021 Antimicrobial Resistance Collaborators","year":"2024","unstructured":"GBD 2021 Antimicrobial Resistance Collaborators. Global burden of bacterial antimicrobial resistance 1990\u20132021: a systematic analysis with forecasts to 2050. Lancet. 2024;404(10459):1199\u2013226.","journal-title":"Lancet"},{"key":"5070_CR9","unstructured":"World Health Organization. WHO Bacterial Priority Pathogens List. 2024: bacterial pathogens of public health importance to guide research, development and strategies to prevent and control antimicrobial resistance. Geneva; 2024. [Accessed on 9 Sept 2025]. Available at: https:\/\/iris.who.int\/bitstream\/handle\/10665\/376776\/9789240093461-eng.pdf?sequence=1"},{"issue":"3","key":"5070_CR10","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1016\/j.jinf.2007.04.007","volume":"55","author":"M Melzer","year":"2007","unstructured":"Melzer M, Petersen I. Mortality following bacteraemic infection caused by extended-spectrum beta-lactamase (ESBL) producing E. coli compared to non-ESBL producing E. coli. J Infect. 2007;55(3):254\u20139.","journal-title":"J Infect"},{"key":"5070_CR11","doi-asserted-by":"publisher","first-page":"189","DOI":"10.2147\/IDR.S391409","volume":"16","author":"EH Yoo","year":"2023","unstructured":"Yoo EH, Hong HL, Kim EJ. Epidemiology and Mortality Analysis Related to Carbapenem-Resistant Enterobacterales in Patients After Admission to Intensive Care Units: An Observational Study. Infect Drug Resist. 2023;16:189\u2013200.","journal-title":"Infect Drug Resist"},{"issue":"3","key":"5070_CR12","doi-asserted-by":"publisher","first-page":"115","DOI":"10.3390\/antibiotics8030115","volume":"8","author":"X Zhen","year":"2019","unstructured":"Zhen X, Lundborg CS, Sun X, Hu X, Dong H. The Clinical and Economic Impact of Antibiotic Resistance in China: A Systematic Review and Meta-Analysis. Antibiot (Basel). 2019;8(3):115.","journal-title":"Antibiot (Basel)"},{"key":"5070_CR13","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1186\/s13756-016-0114-7","volume":"5","author":"A Ndir","year":"2016","unstructured":"Ndir A, Diop A, Ka R, Faye PM, Dia-Badiane NM, Ndoye B, et al. Infections caused by extended-spectrum beta-lactamases-producing Enterobacteriaceae: clinical and economic impact in patients hospitalized in 2 teaching hospitals in Dakar, Senegal. Antimicrob Resist Infect Control. 2016;5:13.","journal-title":"Antimicrob Resist Infect Control"},{"key":"5070_CR14","doi-asserted-by":"publisher","first-page":"2068","DOI":"10.3389\/fmicb.2020.02068","volume":"11","author":"L Gong","year":"2020","unstructured":"Gong L, Tang N, Chen D, Sun K, Lan R, Zhang W, et al. A Nosocomial Respiratory Infection Outbreak of Carbapenem-Resistant Escherichia coli ST131 With Multiple Transmissible blaKPC-2 Carrying Plasmids. Front Microbiol. 2020;11:2068.","journal-title":"Front Microbiol"},{"issue":"1","key":"5070_CR15","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1186\/2047-2994-2-8","volume":"2","author":"M Giuffr\u00e8","year":"2013","unstructured":"Giuffr\u00e8 M, Cipolla D, Bonura C, Geraci DM, Aleo A, Di Noto S, et al. Outbreak of colonizations by extended-spectrum \u03b2-lactamase-producing Escherichia coli sequence type 131 in a neonatal intensive care unit, Italy. Antimicrob Resist Infect Control. 2013;2(1):8.","journal-title":"Antimicrob Resist Infect Control"},{"key":"5070_CR16","doi-asserted-by":"publisher","first-page":"101090","DOI":"10.1016\/j.onehlt.2025.101090","volume":"20","author":"MO Olaitan","year":"2025","unstructured":"Olaitan MO, Orababa OQ, Shittu RB, Obunukwu GM, Kade AE, Arowolo MT, et al. Prevalence of ESBL-producing Escherichia coli in sub-Saharan Africa: A meta-analysis using a One Health approach. One Health. 2025;20:101090.","journal-title":"One Health"},{"issue":"1","key":"5070_CR17","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1186\/s13756-022-01090-2","volume":"11","author":"JEE Acolatse","year":"2022","unstructured":"Acolatse JEE, Portal EAR, Boostrom I, Akafity G, Dakroah MP, Chalker VJ, et al. Environmental surveillance of ESBL and carbapenemase-producing gram-negative bacteria in a Ghanaian Tertiary Hospital. Antimicrob Resist Infect Control. 2022;11(1):49.","journal-title":"Antimicrob Resist Infect Control"},{"issue":"4","key":"5070_CR18","doi-asserted-by":"publisher","first-page":"374","DOI":"10.3390\/antibiotics13040374","volume":"13","author":"M Gashaw","year":"2024","unstructured":"Gashaw M, Gudina EK, Tadesse W, Froeschl G, Ali S, Seeholzer T, et al. Hospital Wastes as Potential Sources for Multi-Drug-Resistant ESBL-Producing Bacteria at a Tertiary Hospital in Ethiopia. Antibiot (Basel). 2024;13(4):374.","journal-title":"Antibiot (Basel)"},{"issue":"2","key":"5070_CR19","doi-asserted-by":"publisher","first-page":"e01906","DOI":"10.1128\/AEM.01906-19","volume":"86","author":"Y Suzuki","year":"2020","unstructured":"Suzuki Y, Nazareno PJ, Nakano R, Mondoy M, Nakano A, Bugayong MP, et al. Environmental Presence and Genetic Characteristics of Carbapenemase-Producing Enterobacteriaceae from Hospital Sewage and River Water in the Philippines. Appl Environ Microbiol. 2020;86(2):e01906\u201319.","journal-title":"Appl Environ Microbiol"},{"issue":"11","key":"5070_CR20","doi-asserted-by":"publisher","first-page":"e0143326","DOI":"10.1371\/journal.pone.0143326","volume":"10","author":"C Dahms","year":"2015","unstructured":"Dahms C, H\u00fcbner NO, Kossow A, Mellmann A, Dittmann K, Kramer A. Occurrence of ESBL-Producing Escherichia coli in Livestock and Farm Workers in Mecklenburg-Western Pomerania, Germany. PLoS ONE. 2015;10(11):e0143326.","journal-title":"PLoS ONE"},{"issue":"6","key":"5070_CR21","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1111\/zph.12612","volume":"66","author":"C Atterby","year":"2019","unstructured":"Atterby C, Osbjer K, Tepper V, Rajala E, Hernandez J, Seng S, et al. Carriage of carbapenemase- and extended-spectrum cephalosporinase-producing Escherichia coli and Klebsiella pneumoniae in humans and livestock in rural Cambodia; gender and age differences and detection of blaOXA-48 in humans. Zoonoses Public Health. 2019;66(6):603\u201317.","journal-title":"Zoonoses Public Health"},{"issue":"6","key":"5070_CR22","doi-asserted-by":"publisher","first-page":"fnx050","DOI":"10.1093\/femsle\/fnx050","volume":"364","author":"RA Stein","year":"2017","unstructured":"Stein RA, Katz DE. Escherichia coli, cattle, and the propagation of disease. FEMS Microbiol Lett. 2017;364(6):fnx050.","journal-title":"FEMS Microbiol Lett"},{"key":"5070_CR23","doi-asserted-by":"publisher","first-page":"100526","DOI":"10.1016\/j.onehlt.2023.100526","volume":"16","author":"MS Islam","year":"2023","unstructured":"Islam MS, Rahman AMMT, Hassan J, Rahman MT. Extended-spectrum beta-lactamase in Escherichia coli isolated from humans, animals, and environments in Bangladesh: A One Health perspective systematic review and meta-analysis. One Health. 2023;16:100526.","journal-title":"One Health"},{"key":"5070_CR24","doi-asserted-by":"publisher","first-page":"127249","DOI":"10.1016\/j.micres.2022.127249","volume":"266","author":"J Ma","year":"2023","unstructured":"Ma J, Song X, Li M, Yu Z, Cheng W, Yu Z, et al. Global spread of carbapenem-resistant Enterobacteriaceae: Epidemiological features, resistance mechanisms, detection and therapy. Microbiol Res. 2023;266:127249.","journal-title":"Microbiol Res"},{"issue":"1","key":"5070_CR25","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1186\/s13756-021-00983-y","volume":"10","author":"E Raphael","year":"2021","unstructured":"Raphael E, Glymour MM, Chambers HF. Trends in prevalence of extended-spectrum beta-lactamase-producing Escherichia coli isolated from patients with community- and healthcare-associated bacteriuria: results from 2014 to 2020 in an urban safety-net healthcare system. Antimicrob Resist Infect Control. 2021;10(1):118.","journal-title":"Antimicrob Resist Infect Control"},{"issue":"43","key":"5070_CR26","doi-asserted-by":"publisher","first-page":"2200934","DOI":"10.2807\/1560-7917.ES.2023.28.43.2200934","volume":"28","author":"H Ilmavirta","year":"2023","unstructured":"Ilmavirta H, Ollgren J, R\u00e4is\u00e4nen K, Kinnunen T, Hakanen AJ, Jalava J, et al. Increasing proportions of extended-spectrum \u03b2-lactamase-producing isolates among Escherichia coli from urine and bloodstream infections: results from a nationwide surveillance network, Finland, 2008 to 2019. Euro Surveill. 2023;28(43):2200934.","journal-title":"Euro Surveill"},{"key":"5070_CR27","doi-asserted-by":"publisher","first-page":"1595652","DOI":"10.3389\/fmicb.2025.1595652","volume":"16","author":"L Di Marcantonio","year":"2025","unstructured":"Di Marcantonio L, Chiatamone Ranieri S, Toro M, Marchegiano A, Cito F, Sulli N, et al. Comprehensive regional study of ESBL Escherichia coli: genomic insights into antimicrobial resistance and inter-source dissemination of ESBL genes. Front Microbiol. 2025;16:1595652.","journal-title":"Front Microbiol"},{"issue":"4","key":"5070_CR28","first-page":"657","volume":"44","author":"WJ Gao","year":"2023","unstructured":"Gao WJ, Liao CX, Li LM. [Introduction for One Health Joint Plan of Action (2022\u20132026)]. Zhonghua Liu Xing Bing Xue Za Zhi. 2023;44(4):657\u201361.","journal-title":"Zhonghua Liu Xing Bing Xue Za Zhi"},{"issue":"1","key":"5070_CR29","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1038\/s42003-023-05745-7","volume":"7","author":"J Huang","year":"2024","unstructured":"Huang J, Lv C, Li M, Rahman T, Chang YF, Guo X, et al. Carbapenem-resistant Escherichia coli exhibit diverse spatiotemporal epidemiological characteristics across the globe. Commun Biol. 2024;7(1):51.","journal-title":"Commun Biol"},{"key":"5070_CR30","doi-asserted-by":"publisher","unstructured":"Woldu MA. Antimicrobial resistance in Ethiopia: current landscape, challenges, and strategic interventions. Discover Med, 2024; 1(1). https:\/\/doi.org\/10.1007\/s44337-024-00090-y","DOI":"10.1007\/s44337-024-00090-y"},{"key":"5070_CR31","doi-asserted-by":"publisher","first-page":"193","DOI":"10.2147\/IDR.S348765","volume":"15","author":"K Geta","year":"2022","unstructured":"Geta K, Kibret M, Knowledge. Attitudes and Practices of Patients on Antibiotic Resistance and Use in Public Hospitals of Amhara Regional State, Northwestern Ethiopia: A Cross-Sectional Study. Infect Drug Resist. 2022;15:193\u2013209.","journal-title":"Infect Drug Resist"},{"issue":"1","key":"5070_CR32","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1186\/s12889-022-12665-4","volume":"22","author":"TT Deneke","year":"2022","unstructured":"Deneke TT, Bekele A, Moore HL, Mamo T, Almaw G, Mekonnen GA, et al. Milk and meat consumption patterns and the potential risk of zoonotic disease transmission among urban and peri-urban dairy farmers in Ethiopia. BMC Public Health. 2022;22(1):222.","journal-title":"BMC Public Health"},{"key":"5070_CR33","doi-asserted-by":"publisher","first-page":"117863022412450","DOI":"10.1177\/11786302241245057","volume":"18","author":"Z Gizaw","year":"2024","unstructured":"Gizaw Z, Yalew AW, Bitew BD, Lee J, Bisesi M. Animal Handling Practice Among Rural Households in Northwest Ethiopia Increases the Risk of Childhood Diarrhea and Exposure to Pathogens From Animal Sources. Environ Health Insights. 2024;18:11786302241245057.","journal-title":"Environ Health Insights"},{"issue":"1","key":"5070_CR34","doi-asserted-by":"publisher","first-page":"e13720","DOI":"10.1111\/mcn.13720","volume":"21","author":"T Zerfu","year":"2025","unstructured":"Zerfu T, Duncan A, Baltenweck I, McNeill G. Low awareness and affordability are major drivers of low consumption of animal-source foods among children in Northern Ethiopia: A mixed-methods study. Matern Child Nutr. 2025;21(1):e13720.","journal-title":"Matern Child Nutr"},{"issue":"1","key":"5070_CR35","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1186\/s13756-024-01368-7","volume":"13","author":"Z Asmare","year":"2024","unstructured":"Asmare Z, Awoke T, Genet C, Admas A, Melese A, Mulu W. Incidence of catheter-associated urinary tract infections by Gram-negative bacilli and their ESBL and carbapenemase production in specialized hospitals of Bahir Dar, northwest Ethiopia. Antimicrob Resist Infect Control. 2024;13(1):10.","journal-title":"Antimicrob Resist Infect Control"},{"key":"5070_CR36","unstructured":"Organization WH, Basic Laboratory Procedures in Clinical Bacteriology. 1991. [accessed on 9 September 2024]. Available at: https:\/\/iris.who.int\/bitstream\/handle\/10665\/42696\/9241545453.pdf?sequence=1"},{"key":"5070_CR37","doi-asserted-by":"publisher","first-page":"5727638","DOI":"10.1155\/2022\/5727638","volume":"2022","author":"S Tadesse","year":"2022","unstructured":"Tadesse S, Mulu W, Genet C, Kibret M, Belete MA. Emergence of High Prevalence of Extended-Spectrum Beta-Lactamase and Carbapenemase-Producing Enterobacteriaceae Species among Patients in Northwestern Ethiopia Region. Biomed Res Int. 2022;2022:5727638.","journal-title":"Biomed Res Int"},{"issue":"10","key":"5070_CR38","doi-asserted-by":"publisher","first-page":"6431","DOI":"10.1128\/AEM.71.10.6431-6433.2005","volume":"71","author":"MA Greenquist","year":"2005","unstructured":"Greenquist MA, Drouillard JS, Sargeant JM, Depenbusch BE, Shi X, Lechtenberg KF, et al. Comparison of rectoanal mucosal swab cultures and fecal cultures for determining prevalence of Escherichia coli O157:H7 in feedlot cattle. Appl Environ Microbiol. 2005;71(10):6431\u20133.","journal-title":"Appl Environ Microbiol"},{"issue":"5","key":"5070_CR39","doi-asserted-by":"publisher","first-page":"3766","DOI":"10.1128\/AEM.72.5.3766-3770.2006","volume":"72","author":"MA Davis","year":"2006","unstructured":"Davis MA, Rice DH, Sheng H, Hancock DD, Besser TE, Cobbold R, et al. Comparison of cultures from rectoanal-junction mucosal swabs and feces for detection of Escherichia coli O157 in dairy heifers. Appl Environ Microbiol. 2006;72(5):3766\u201370.","journal-title":"Appl Environ Microbiol"},{"issue":"4","key":"5070_CR40","doi-asserted-by":"publisher","first-page":"1183","DOI":"10.3390\/ijerph17041183","volume":"17","author":"L Zhang","year":"2020","unstructured":"Zhang L, Ma X, Luo L, Hu N, Duan J, Tang Z, et al. The Prevalence and Characterization of Extended-Spectrum \u03b2-Lactamase- and Carbapenemase-Producing Bacteria from Hospital Sewage, Treated Effluents and Receiving Rivers. Int J Environ Res Public Health. 2020;17(4):1183.","journal-title":"Int J Environ Res Public Health"},{"issue":"1","key":"5070_CR41","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1186\/s12866-024-03297-2","volume":"24","author":"T Kahsay","year":"2024","unstructured":"Kahsay T, Gebrehiwot GT, Gebreyohannes G, Tilahun M, Gessese A, Kahsay A. Antimicrobial susceptibility patterns of urinary tract infections causing bacterial isolates and associated risk factors among HIV patients in Tigray, Northern Ethiopia. BMC Microbiol. 2024;24(1):148.","journal-title":"BMC Microbiol"},{"issue":"1","key":"5070_CR42","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1186\/2047-2994-3-5","volume":"3","author":"JT Freeman","year":"2014","unstructured":"Freeman JT, Nimmo J, Gregory E, Tiong A, De Almeida M, McAuliffe GN, et al. Predictors of hospital surface contamination with Extended-spectrum \u03b2-lactamase-producing Escherichia coli and Klebsiella pneumoniae: patient and organism factors. Antimicrob Resist Infect Control. 2014;3(1):5.","journal-title":"Antimicrob Resist Infect Control"},{"key":"5070_CR43","doi-asserted-by":"crossref","unstructured":"Cheesbrough M. District laboratory practice in tropical countries. Part 2. 2nd edition. Cambridge: Cambridge University Press; 2006.","DOI":"10.1017\/CBO9780511543470"},{"key":"5070_CR44","unstructured":"Clinical Laboratory Standard Institute. Performance Standards for Antimicrobial Susceptibility Testing. 33rd ed. CLSI supplement M100. Clinical and Laboratory Standards Institute; 2023."},{"issue":"3","key":"5070_CR45","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1111\/j.1469-0691.2011.03570.x","volume":"18","author":"AP Magiorakos","year":"2012","unstructured":"Magiorakos AP, Srinivasan A, Carey RB, Carmeli Y, Falagas ME, Giske CG, et al. Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance. Clin Microbiol Infect. 2012;18(3):268\u201381.","journal-title":"Clin Microbiol Infect"},{"issue":"2","key":"5070_CR46","doi-asserted-by":"publisher","first-page":"61","DOI":"10.3390\/antibiotics9020061","volume":"9","author":"I Karaiskos","year":"2020","unstructured":"Karaiskos I, Giamarellou H. Carbapenem-Sparing Strategies for ESBL Producers: When and How. Antibiot (Basel). 2020;9(2):61.","journal-title":"Antibiot (Basel)"},{"issue":"7","key":"5070_CR47","doi-asserted-by":"publisher","first-page":"972","DOI":"10.1093\/cid\/cix034","volume":"64","author":"PD Tamma","year":"2017","unstructured":"Tamma PD, Rodriguez-Bano J. The Use of Noncarbapenem \u03b2-Lactams for the Treatment of Extended-Spectrum \u03b2-Lactamase Infections. Clin Infect Dis. 2017;64(7):972\u201380.","journal-title":"Clin Infect Dis"},{"issue":"5","key":"5070_CR48","doi-asserted-by":"publisher","first-page":"1244","DOI":"10.1128\/jb.89.5.1244-1249.1965","volume":"89","author":"K Maki Lr, Picard","year":"1965","unstructured":"Maki Lr, Picard K. Normal intestinal flora of cattle fed high-roughage rations. J Bacteriol. 1965;89(5):1244\u20139.","journal-title":"J Bacteriol"},{"issue":"3","key":"5070_CR49","doi-asserted-by":"publisher","first-page":"fuac008","DOI":"10.1093\/femsre\/fuac008","volume":"46","author":"E Foster-Nyarko","year":"2022","unstructured":"Foster-Nyarko E, Pallen MJ. The microbial ecology of Escherichia coli in the vertebrate gut. FEMS Microbiol Rev. 2022;46(3):fuac008.","journal-title":"FEMS Microbiol Rev"},{"issue":"10","key":"5070_CR50","doi-asserted-by":"publisher","first-page":"6140","DOI":"10.1002\/fsn3.3550","volume":"11","author":"AA Tarekegn","year":"2023","unstructured":"Tarekegn AA, Mitiku BA, Alemu YF. Escherichia coli O157:H7 beef carcass contamination and its antibiotic resistance in Awi Zone, Northwest Ethiopia. Food Sci Nutr. 2023;11(10):6140\u201350.","journal-title":"Food Sci Nutr"},{"key":"5070_CR51","doi-asserted-by":"publisher","first-page":"115","DOI":"10.4067\/S0719-81322022000300115","volume":"54","author":"D Boudjerdaa","year":"2022","unstructured":"Boudjerdaa D, Lahouela M. Virulence and antimicrobial resistance of Escherichia coli isolated from chicken meat, beef, and raw milk. Austral J Vet Sci. 2022;54:115\u201325.","journal-title":"Austral J Vet Sci"},{"issue":"2","key":"5070_CR52","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1177\/003335490512000211","volume":"120","author":"RL Vogt","year":"2005","unstructured":"Vogt RL, Dippold L. Escherichia coli O157:H7 outbreak associated with consumption of ground beef, June-July 2002. Public Health Rep. 2005;120(2):174\u20138.","journal-title":"Public Health Rep"},{"issue":"11","key":"5070_CR53","doi-asserted-by":"publisher","first-page":"1355","DOI":"10.3390\/pathogens10111355","volume":"10","author":"VM Sora","year":"2021","unstructured":"Sora VM, Meroni G, Martino PA, Soggiu A, Bonizzi L, Zecconi A. Extraintestinal Pathogenic Escherichia coli: Virulence Factors and Antibiotic Resistance. Pathogens. 2021;10(11):1355.","journal-title":"Pathogens"},{"issue":"12","key":"5070_CR54","doi-asserted-by":"publisher","first-page":"1816","DOI":"10.1038\/s41372-024-02117-9","volume":"44","author":"A Hoffman","year":"2024","unstructured":"Hoffman A, Satyavolu S, Muhanna D, Malay S, Raffay T, Windau A, et al. Predictors of mortality and severe illness from Escherichia coli sepsis in neonates. J Perinatol. 2024;44(12):1816\u201321.","journal-title":"J Perinatol"},{"issue":"2","key":"5070_CR55","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1038\/ismej.2010.80","volume":"5","author":"JD van Elsas","year":"2011","unstructured":"van Elsas JD, Semenov AV, Costa R, Trevors JT. Survival of Escherichia coli in the environment: fundamental and public health aspects. ISME J. 2011;5(2):173\u201383.","journal-title":"ISME J"},{"issue":"1","key":"5070_CR56","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1186\/s12941-023-00638-3","volume":"22","author":"T Ramatla","year":"2023","unstructured":"Ramatla T, Mafokwane T, Lekota K, Monyama M, Khasapane G, Serage N, et al. One Health perspective on prevalence of co-existing extended-spectrum beta-lactamase (ESBL)-producing Escherichia coli and Klebsiella pneumoniae: a comprehensive systematic review and meta-analysis. Ann Clin Microbiol Antimicrob. 2023;22(1):88.","journal-title":"Ann Clin Microbiol Antimicrob"},{"key":"5070_CR57","doi-asserted-by":"publisher","first-page":"1181","DOI":"10.2147\/IDR.S201324","volume":"12","author":"A Pormohammad","year":"2019","unstructured":"Pormohammad A, Nasiri MJ, Azimi T. Prevalence of antibiotic resistance in Escherichia coli strains simultaneously isolated from humans, animals, food, and the environment: a systematic review and meta-analysis. Infect Drug Resist. 2019;12:1181\u201397.","journal-title":"Infect Drug Resist"},{"issue":"6","key":"5070_CR58","doi-asserted-by":"publisher","first-page":"e0001344","DOI":"10.1371\/journal.pgph.0001344","volume":"3","author":"J Muleme","year":"2023","unstructured":"Muleme J, Musoke D, Balugaba BE, Kisaka S, Makumbi FE, Buregyeya E, et al. Epidemiology of extended-spectrum beta-lactamase-producing Escherichia coli at the human-animal-environment interface in a farming community of central Uganda. PLOS Glob Public Health. 2023;3(6):e0001344.","journal-title":"PLOS Glob Public Health"},{"issue":"1","key":"5070_CR59","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1186\/s42522-025-00154-8","volume":"7","author":"MA Olu-Taiwo","year":"2025","unstructured":"Olu-Taiwo MA, Egyir B, Owusu-Nyantakyi C, Forson AO, Opintan JA. Molecular characterization of multidrug-resistant Escherichia coli in the Greater Accra Region, Ghana: a \u2018One Health\u2019 approach. One Health Outlook. 2025;7(1):31.","journal-title":"One Health Outlook"},{"key":"5070_CR60","doi-asserted-by":"publisher","unstructured":"Atnkut B, Nigussie A, Gebreamanule B, Kumera B, Astatkie T. Assessment of inappropriate use of antibiotics and contributing factors in Awi Administrative Zone, Northwestern Amhara regional State, Ethiopia. New Microbes New Infect. 2024;63:101557. https:\/\/doi.org\/10.1016\/j.nmni.2024.101557","DOI":"10.1016\/j.nmni.2024.101557"},{"issue":"1","key":"5070_CR61","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1186\/s13756-024-01502-5","volume":"13","author":"A Muhummed","year":"2024","unstructured":"Muhummed A, Alemu A, Hosch S, Osman Y, Tschopp R, Yersin S, et al. Fecal carriage of ESBL-producing E. coli and genetic characterization in rural children and livestock in the Somali region, Ethiopia: a one health approach. Antimicrob Resist Infect Control. 2024;13(1):148.","journal-title":"Antimicrob Resist Infect Control"},{"issue":"4","key":"5070_CR62","doi-asserted-by":"publisher","first-page":"2286","DOI":"10.3390\/microbiolres15040153","volume":"15","author":"D Soma","year":"2024","unstructured":"Soma D, Bonkoungou IJO, Garba Z, Diarra FBJ, Somda NS, Nikiema MEM, et al. Extended-Spectrum Beta-Lactamase-Producing and Multidrug-Resistant Escherichia coli and Klebsiella spp. from the Human\u2013Animal\u2013Environment Interface on Cattle Farms in Burkina Faso. Microbiol Res. 2024;15(4):2286\u201397.","journal-title":"Microbiol Res"},{"key":"5070_CR63","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1016\/j.jgar.2019.07.031","volume":"20","author":"TTH Van","year":"2020","unstructured":"Van TTH, Yidana Z, Smooker PM, Coloe PJ. Antibiotic use in food animals worldwide, with a focus on Africa: Pluses and minuses. J Glob Antimicrob Resist. 2020;20:170\u20137.","journal-title":"J Glob Antimicrob Resist"},{"issue":"18","key":"5070_CR64","doi-asserted-by":"publisher","first-page":"5649","DOI":"10.1073\/pnas.1503141112","volume":"112","author":"TP Van Boeckel","year":"2015","unstructured":"Van Boeckel TP, Brower C, Gilbert M, Grenfell BT, Levin SA, Robinson TP, et al. Global trends in antimicrobial use in food animals. Proc Natl Acad Sci U S A. 2015;112(18):5649\u201354.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"5070_CR65","doi-asserted-by":"publisher","first-page":"55","DOI":"10.3389\/fvets.2020.00055","volume":"7","author":"BA Gemeda","year":"2020","unstructured":"Gemeda BA, Amenu K, Magnusson U, Dohoo I, Hallenberg GS, Alemayehu G, et al. Antimicrobial Use in Extensive Smallholder Livestock Farming Systems in Ethiopia: Knowledge, Attitudes, and Practices of Livestock Keepers. Front Vet Sci. 2020;7:55.","journal-title":"Front Vet Sci"},{"key":"5070_CR66","doi-asserted-by":"publisher","first-page":"1167847","DOI":"10.3389\/fvets.2023.1167847","volume":"10","author":"TB Tufa","year":"2023","unstructured":"Tufa TB, Regassa F, Amenu K, Stegeman JA, Hogeveen H. Livestock producers\u2019 knowledge, attitude, and behavior (KAB) regarding antimicrobial use in Ethiopia. Front Vet Sci. 2023;10:1167847.","journal-title":"Front Vet Sci"},{"issue":"4","key":"5070_CR67","doi-asserted-by":"publisher","first-page":"e96101","DOI":"10.1371\/journal.pone.0096101","volume":"9","author":"T Sato","year":"2014","unstructured":"Sato T, Okubo T, Usui M, Yokota S, Izumiyama S, Tamura Y. Association of veterinary third-generation cephalosporin use with the risk of emergence of extended-spectrum-cephalosporin resistance in Escherichia coli from dairy cattle in Japan. PLoS ONE. 2014;9(4):e96101.","journal-title":"PLoS ONE"},{"key":"5070_CR68","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1186\/s13756-015-0054-7","volume":"4","author":"S Eshetie","year":"2015","unstructured":"Eshetie S, Unakal C, Gelaw A, Ayelign B, Endris M, Moges F. Multidrug resistant and carbapenemase producing Enterobacteriaceae among patients with urinary tract infection at referral Hospital, Northwest Ethiopia. Antimicrob Resist Infect Control. 2015;4:12.","journal-title":"Antimicrob Resist Infect Control"},{"key":"5070_CR69","doi-asserted-by":"publisher","first-page":"1367","DOI":"10.2147\/IDR.S349566","volume":"15","author":"A Seman","year":"2022","unstructured":"Seman A, Mihret A, Sebre S, Awoke T, Yeshitela B, Yitayew B, et al. Prevalence and Molecular Characterization of Extended-Spectrum \u03b2-Lactamase and Carbapenemase-Producing Enterobacteriaceae Isolates from Bloodstream Infection Suspected Patients in Addis Ababa, Ethiopia. Infect Drug Resist. 2022;15:1367\u201382.","journal-title":"Infect Drug Resist"},{"key":"5070_CR70","doi-asserted-by":"publisher","first-page":"167160","DOI":"10.1016\/j.scitotenv.2023.167160","volume":"905","author":"HS Mohamed","year":"2023","unstructured":"Mohamed HS, Galal L, Hayer J, Benavides JA, Ba\u00f1uls AL, Dupont C, et al. Genomic epidemiology of carbapenemase-producing Gram-negative bacteria at the human-animal-environment interface in Djibouti city. Djibouti Sci Total Environ. 2023;905:167160.","journal-title":"Djibouti Sci Total Environ"},{"issue":"1","key":"5070_CR71","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1186\/s12879-025-10506-4","volume":"25","author":"Z Garba","year":"2025","unstructured":"Garba Z, Bonkoungou IJO, Somda NS, Natama MH, Som\u00e9 G, Sangar\u00e9 L, et al. Fecal carriage of carbapenemase and AmpC-\u03b2-lactamase producers among extended-spectrum \u03b2-Lactamase-producing E. coli and Klebsiella spp. isolates in patients attending hospitals. BMC Infect Dis. 2025;25(1):109.","journal-title":"BMC Infect Dis"},{"issue":"1","key":"5070_CR72","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1186\/s12894-025-01695-w","volume":"25","author":"M Tigabie","year":"2025","unstructured":"Tigabie M, Ayalew G, Demoze L, Tadesse K, Gashaw Y, Assefa M. Extended-spectrum beta-lactamase and carbapenemase-producing Gram-negative bacteria in urinary tract infections in Ethiopia: a systematic review and meta-analysis. BMC Urol. 2025;25(1):11.","journal-title":"BMC Urol"},{"key":"5070_CR73","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1186\/s13756-017-0272-2","volume":"6","author":"DA Erku","year":"2017","unstructured":"Erku DA, Mekuria AB, Belachew SA. Inappropriate use of antibiotics among communities of Gondar town, Ethiopia: a threat to the development of antimicrobial resistance. Antimicrob Resist Infect Control. 2017;6:112.","journal-title":"Antimicrob Resist Infect Control"},{"issue":"9","key":"5070_CR74","doi-asserted-by":"publisher","first-page":"e0138179","DOI":"10.1371\/journal.pone.0138179","volume":"10","author":"E Gebeyehu","year":"2015","unstructured":"Gebeyehu E, Bantie L, Azage M. Inappropriate Use of Antibiotics and Its Associated Factors among Urban and Rural Communities of Bahir Dar City Administration, Northwest Ethiopia. PLoS ONE. 2015;10(9):e0138179.","journal-title":"PLoS ONE"},{"issue":"7","key":"5070_CR75","doi-asserted-by":"publisher","first-page":"e0288243","DOI":"10.1371\/journal.pone.0288243","volume":"18","author":"B Tuhamize","year":"2023","unstructured":"Tuhamize B, Asiimwe BB, Kasaza K, Sabiiti W, Holden M, Bazira J. Klebsiella pneumoniae carbapenamases in Escherichia coli isolated from humans and livestock in rural south-western Uganda. PLoS ONE. 2023;18(7):e0288243.","journal-title":"PLoS ONE"},{"key":"5070_CR76","unstructured":"World Health Organization. The WHO AWaRe (Access, Watch, Reserve) antibiotic book. Geneva, World Health Organization. : 2022. Licence: CC BY-NC-SA 3.0 IGO. [Accessed on 9 September 2025]. Available at: https:\/\/iris.who.int\/server\/api\/core\/bitstreams\/61517f8b-3a34-413c-ae36-67a059ebe485\/content."},{"key":"5070_CR77","unstructured":"Ethiopian Food and Drug Authority, Ministry of Health. Ethiopian Essential Medicines List. 7th edition. Addis Ababa: Ethiopia Food and Drug Authority. [Accessed on 15 December 2025]. Available at: https:\/\/www.efda.gov.et\/wp-content\/uploads\/2025\/02\/Ethiopian-Essential-Medicines-List-Oct-2024.pdf"},{"key":"5070_CR78","unstructured":"World Health Organization. The selection and use of essential medicines, 2025: WHO Model List of Essential Medicines, 24th list. Geneva: World Health Organization. 2025. [Accessed on 15 December 2025]. Available at: https:\/\/iris.who.int\/server\/api\/core\/bitstreams\/17642505-ecd3-4940-a691-4f1dfa0d835a\/content"},{"issue":"3","key":"5070_CR79","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1016\/j.pedneo.2023.04.021","volume":"65","author":"XT He","year":"2024","unstructured":"He XT, Chang CN, Yu CH, Wang CC. The risk factors, antimicrobial resistance patterns, and outcomes associated with extended-spectrum \u03b2-lactamases-Producing pathogens in pediatric urinary tract infection. Pediatr Neonatol. 2024;65(3):242\u20138.","journal-title":"Pediatr Neonatol"},{"issue":"1","key":"5070_CR80","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1186\/s12864-022-08564-y","volume":"23","author":"K Juraschek","year":"2022","unstructured":"Juraschek K, Malekzadah J, Malorny B, K\u00e4sbohrer A, Schwarz S, Meemken D, et al. Characterization of qnrB-carrying plasmids from ESBL- and non-ESBL-producing Escherichia coli. BMC Genomics. 2022;23(1):365.","journal-title":"BMC Genomics"},{"key":"5070_CR81","doi-asserted-by":"publisher","unstructured":"Poirel L, Madec JY, Lupo A, Schink AK, Kieffer N, Nordmann P, et al. Antimicrobial Resistance in Escherichia coli. Microbiol Spectr. 2018;6(4). https:\/\/doi.org\/10.1128\/microbiolspec.arba-0026-2017.","DOI":"10.1128\/microbiolspec.arba-0026-2017"},{"issue":"3","key":"5070_CR82","doi-asserted-by":"publisher","first-page":"dlae068","DOI":"10.1093\/jacamr\/dlae068","volume":"6","author":"Z Asmare","year":"2024","unstructured":"Asmare Z, Erkihun M, Abebe W, Tamrat E. Antimicrobial resistance and ESBL production in uropathogenic Escherichia coli: a systematic review and meta-analysis in Ethiopia. JAC Antimicrob Resist. 2024;6(3):dlae068.","journal-title":"JAC Antimicrob Resist"},{"key":"5070_CR83","doi-asserted-by":"publisher","first-page":"7676973","DOI":"10.1155\/bmri\/7676973","volume":"2025","author":"AA Abejew","year":"2025","unstructured":"Abejew AA, Fenta TG, Wubetu GY. A Six Years\u2019 Trend Analysis of Antimicrobial Resistance Among Bacterial Isolates at Public Health Institute in Amhara Region, Ethiopia. Biomed Res Int. 2025;2025:7676973.","journal-title":"Biomed Res Int"},{"key":"5070_CR84","doi-asserted-by":"publisher","first-page":"4025","DOI":"10.2147\/IDR.S412350","volume":"16","author":"MG Gebremedhin","year":"2023","unstructured":"Gebremedhin MG, Weldu Y, Kahsay AG, Teame G, Adane K. Extended-Spectrum \u03b2-Lactamase and Carbapenemase-Producing Gram-Negative Bacteria and Associated Factors Among Patients Suspected of Community and Hospital-Acquired Urinary Tract Infections at Ayder Comprehensive Specialized Hospital, Tigrai, Ethiopia. Infect Drug Resist. 2023;16:4025\u201337.","journal-title":"Infect Drug Resist"},{"issue":"10","key":"5070_CR85","doi-asserted-by":"publisher","first-page":"e0274156","DOI":"10.1371\/journal.pone.0274156","volume":"18","author":"J Sampah","year":"2023","unstructured":"Sampah J, Owusu-Frimpong I, Aboagye FT, Owusu-Ofori A. Prevalence of carbapenem-resistant and extended-spectrum beta-lactamase-producing Enterobacteriaceae in a teaching hospital in Ghana. PLoS ONE. 2023;18(10):e0274156.","journal-title":"PLoS ONE"},{"key":"5070_CR86","doi-asserted-by":"publisher","first-page":"9956724","DOI":"10.1155\/ijm\/9956724","volume":"2025","author":"A Kumar","year":"2025","unstructured":"Kumar A, Bumunang EW, Montso PK, Singh S, Ateba CN. Multidrug-Resistant Virulent Escherichia coli Strains in Cattle: Implications on Food Safety and Public Health. Int J Microbiol. 2025;2025:9956724.","journal-title":"Int J Microbiol"},{"issue":"9","key":"5070_CR87","doi-asserted-by":"publisher","first-page":"1137","DOI":"10.3390\/antibiotics10091137","volume":"10","author":"VS Sonola","year":"2021","unstructured":"Sonola VS, Katakweba AS, Misinzo G, Matee MIN. Occurrence of Multi-Drug-Resistant Escherichia coli in Chickens, Humans, Rodents and Household Soil in Karatu, Northern Tanzania. Antibiot (Basel). 2021;10(9):1137.","journal-title":"Antibiot (Basel)"},{"key":"5070_CR88","doi-asserted-by":"publisher","first-page":"137","DOI":"10.3390\/antibiotics14020137","volume":"14","author":"Y Veloo","year":"2025","unstructured":"Veloo Y, Rajendiran S, Zakaria Z, Ismail R, Rahman SA, Mansor R, et al. Prevalence and Antimicrobial Resistance Patterns of Escherichia coli in the Environment, Cow Dung, and Milk of Selangor Dairy Farms. Antibiotics. 2025;14:137.","journal-title":"Antibiotics"},{"issue":"1","key":"5070_CR89","doi-asserted-by":"publisher","first-page":"e0317874","DOI":"10.1371\/journal.pone.0317874","volume":"20","author":"EM James","year":"2025","unstructured":"James EM, Kimera ZI, Mgaya FX, Niccodem EM, Efraim JE, Matee MI, et al. Occurrence of virulence genes in multidrug-resistant Escherichia coli isolates from humans, animals, and the environment: One health perspective. PLoS ONE. 2025;20(1):e0317874.","journal-title":"PLoS ONE"},{"key":"5070_CR90","doi-asserted-by":"publisher","first-page":"e70034","DOI":"10.1002\/puh2.70034","volume":"4","author":"H Ehsan","year":"2025","unstructured":"Ehsan H. Antibiotic Resistance in Developing Countries: Emerging Threats and Policy Responses. Public Health Challenges. 2025;4:e70034.","journal-title":"Public Health Challenges"},{"issue":"3","key":"5070_CR91","doi-asserted-by":"publisher","first-page":"900","DOI":"10.1128\/JCM.02071-09","volume":"48","author":"SQ van Veen","year":"2010","unstructured":"van Veen SQ, Claas EC, Kuijper EJ. High-throughput identification of bacteria and yeast by matrix-assisted laser desorption ionization-time of flight mass spectrometry in conventional medical microbiology laboratories. J Clin Microbiol. 2010;48(3):900\u20137.","journal-title":"J Clin Microbiol"},{"issue":"1","key":"5070_CR92","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1186\/s12866-017-1037-z","volume":"17","author":"A Kassim","year":"2017","unstructured":"Kassim A, Pfl\u00fcger V, Premji Z, Daubenberger C, Revathi G. Comparison of biomarker based Matrix Assisted Laser Desorption Ionization-Time of Flight Mass Spectrometry (MALDI-TOF MS) and conventional methods in the identification of clinically relevant bacteria and yeast. BMC Microbiol. 2017;17(1):128.","journal-title":"BMC Microbiol"},{"key":"5070_CR93","doi-asserted-by":"publisher","first-page":"608901","DOI":"10.3389\/fvets.2020.608901","volume":"7","author":"S Horsman","year":"2021","unstructured":"Horsman S, Rynhoud H, Zhou X, Soares Magalh\u00e3es RJ, Gibson JS, Meler E. Environmental Recovery of Nosocomial Bacteria in a Companion Animal Shelter Before and After Infection Control Procedures. Front Vet Sci. 2021;7:608901.","journal-title":"Front Vet Sci"}],"container-title":["BMC Microbiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12866-026-05070-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12866-026-05070-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12866-026-05070-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T02:03:20Z","timestamp":1783044200000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12866-026-05070-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,22]]},"references-count":93,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["5070"],"URL":"https:\/\/doi.org\/10.1186\/s12866-026-05070-z","relation":{},"ISSN":["1471-2180"],"issn-type":[{"value":"1471-2180","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,22]]},"assertion":[{"value":"4 December 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was ethically approved by Bahir Dar University Institute of Biotechnology Institutional Research Ethics Review Committee (IRERC) with reference number IoB-IRERC\/001\/2024. This research was conducted in accordance with the ethical principles of Helsinki. Informed written consent was obtained from patients aged 18 years or older who were clinically presumptive for UTI or septicemia. Consent was obtained from parents, next-of-kin, or guardian of a child aged less than 18 years and clinically diagnosed as having septicemia or UTI. Besides the consent from their guardian, next-of-kin, or guardian, assent was obtained from children aged between 12 and 18 years who were clinically diagnosed as having UTI or septicemia. Moreover, verbal informed consent was obtained from owners of animals and farms before data collection. The use of verbal consent was also approved by the IRERC.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"586"}}